Associate Professor of Medicine, Dana-Farber Cancer Institute
Hematology
Dr. Lawrence N. Shulman, MD
|
|
Give Review
Lawrence Shulman practices Hematology. He researched medicine at Harvard Medical School. Harvard Medical School is a top medical college. Harvard Medical School is ranked 1/12 in Research/PrimaryCare. He has 5 awards "America's Top Doctors", "Boston Magazine", "America's Top Doctors for Cancer", "Super Doctor" and "Top MD". Lawrence Shulman is also published. He has 40 publications published. The lastest publication: "Proposing Essential Medicines to Treat Cancer: Methodologies, Processes, and Outcomes.' Dr. Lawrence N. Shulman accepts Medicare payments and is listed with Medicare.gov.
Publications
- Proposing Essential Medicines to Treat Cancer: Methodologies, Processes, and Outcomes.
- Bringing Cancer care to the poor: experiences from Rwanda.
- Comparison of Doxorubicin and Cyclophosphamide Versus Single-Agent Paclitaxel As Adjuvant Therapy for Breast Cancer in Women With 0 to 3 Positive Axillary Nodes: CALGB...
- Rwanda 20 years on: investing in life.
- Polygenic inheritance of paclitaxel-induced sensory peripheral neuropathy driven by axon outgrowth gene sets in CALGB 40101 (Alliance).
- Comparing clinicians' use of an anticoagulation management service and usual care in ambulatory oncology.
- Integration of Cell Line and Clinical Trial Genome-Wide Analyses Supports a Polygenic Architecture of Paclitaxel-Induced Sensory Peripheral Neuropathy.
- Tumor boards and the quality of Cancer care.
- Improving electronic oral chemotherapy prescription: can we build a safer system?
- Six cycles of doxorubicin and cyclophosphamide or Paclitaxel are not superior to four cycles as adjuvant chemotherapy for breast Cancer in women with zero to three pos...
- Identifying women at risk of delayed breast Cancer diagnosis.
- Occult primary.
- Relationship between Quantitative GRB7 RNA Expression and Recurrence after Adjuvant Anthracycline Chemotherapy in Triple-Negative Breast Cancer.
- Quality of care for older patients with Cancer in the veterans health administration versus the private sector: a cohort study.
- Report on the ASCO 2010 Provider-Payer Initiative Meeting.
- Will we be able to care for Cancer patients in the future?
- Models of multidisciplinary Cancer care: physician and patient perceptions in a comprehensive Cancer center.
- Update in hematology and oncology.
- Medication errors involving oral chemotherapy.
- Partners in pathology: a collaborative model to bring pathology to resource poor settings.
- Relationship between Topoisomerase 2A RNA Expression and Recurrence after Adjuvant Chemotherapy for Breast Cancer.
- Provider practice models in ambulatory oncology practice: analysis of productivity, revenue, and provider and patient satisfaction.
- Process of care failures in breast Cancer diagnosis.
- Cancer Care and Cancer Survivorship Care in the United States: Will We Be Able to Care for These Patients in the Future?
- VEGF as a marker for outcome among advanced breast Cancer patients receiving anti-VEGF therapy with bevacizumab and vinorelbine chemotherapy.
- Prognostic utility of the 21-gene assay in hormone receptor-positive operable breast Cancer compared with classical clinicopathologic features.
- Concurrent doxorubicin plus docetaxel is not more effective than concurrent doxorubicin plus cyclophosphamide in operable breast Cancer with 0 to 3 positive axillary n...
- Impact of quality management monitoring and intervention on central venous catheter dysfunction in the outpatient chemotherapy infusion setting.
- Case records of the Massachusetts General Hospital. Case 4-2008. A 33-year-old pregnant woman with swelling of the left Breast and shortness of breath.
- Medication reconciliation in ambulatory oncology.
- Sarcoidosis mimicking metastatic breast Cancer.
- Phase II study of CT-2103 as first- or second-line chemotherapy in patients with metastatic breast Cancer: unexpected incidence of hypersensitivity reactions.
- Medication safety in the ambulatory chemotherapy setting.
- Sequencing of chemotherapy and radiation therapy in early-stage breast Cancer: updated results of a prospective randomized trial.
- Impact of an Electronic Health Record on oncologists' clinic time.
- Lack of efficacy of streptozocin and doxorubicin in patients with advanced pancreatic endocrine Tumors.
- A prospective study of concurrent cyclophosphamide/methotrexate/5-fluorouracil and reduced-dose radiotherapy in patients with early-stage Breast carcinoma.
- Phase I clinical trial of recombinant human endostatin administered as a short intravenous infusion repeated daily.
- Difficulties in implementing an organized screening program for breast Cancer in Brazil with emphasis on diagnostic methods.
Schools
Harvard Medical School
Beth Israel Hospital
Beth Israel Hospital Harvard
Procedures Preformed
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Anemia
- Bladder Cancer
- Breast Cancer
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Blue Card PPO
- BlueConnect HMO
- Blue with Managed Care Behavioral Health HMO
- Preferred Blue PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- Coventry Health Care
- Fallon Community Health Plan
- First Health (Coventry Health Care) PPO
- GEHA
- Harvard Pilgrim Health Care PPO
- Choice Care PPO
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Neighborhood Health Plan
- Tufts Health Plans
- Tufts PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Awards
- America's Top Doctors
- Boston Magazine
- America's Top Doctors for Cancer
- Super Doctor
- Top MD
Education
-
Beth Israel Deaconess Medical Center -
Harvard Medical School
Hospital
-
Massachusetts General Hospital -
Dana-Farber Cancer Institute -
Brigham and Women's Hospital
Helpful Reviews
Similar Doctors
|
|
Dr. Thomas J. Schuetz, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Carl J. O'Hara, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Arthur T. Skarin, MD |
|
|
Dr. Jerome Ritz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bruce E. Johnson, MD |
|
|
Dr. Glenn Dranoff, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marion F. Baxter, MD |
|
|
Dr. Margaret A. Shipp, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Carl J. O'Hara, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Suzanne George, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edwin P. Alyea III, MD
This Doctor is OpenDoctor Recommended.
|